Management of paracetamol poisoning

An ultra scale-down analysis of the recovery by dead-end centrifugation of human cells for therapy.

Biotechnology and bioengineering·2014

Use of adenovirus as a model system to illustrate a simple method using standard equipment and inexpensive excipients to remove live virus dependence on the cold-chain.

Vaccine·2014

CB₁-independent mechanisms of Δ⁹-THCV, AM251 and SR141716 (rimonabant).

Journal of clinical pharmacy and therapeutics·2011

The micromass test: Is it subject to strain variation?

Toxicology in vitro : an international journal published in association with BIBRA·2010

The endocannabinoid system and rimonabant: a new drug with a novel mechanism of action involving cannabinoid CB1 receptor antagonism--or inverse agonism--as potential obesity treatment and other therapeutic use.

Journal of clinical pharmacy and therapeutics·2007

A nonsynonymous substitution of cystatin A, a cysteine protease inhibitor of house dust mite protease, leads to decreased mRNA stability and shows a significant association with atopic dermatitis.

Allergy·2007

Efficacy and safety of upadacitinib in adults and adolescents for treatment of non-segmental vitiligo (Viti-Up): results of two phase 3 randomised controlled studies.

Lancet (London, England)·2026

Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Switch to once-weekly, single-tablet islatravir-lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial.

Lancet (London, England)·2026

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Lancet (London, England)·2026

Defining nonfatal opioid overdoses using administrative health data in the United States and Canada: A scoping review.

Preventive medicine reports·2026

Opioid antagonist treatment in alcohol use disorder: extinction, reward memory, and the possible importance of timing.

Frontiers in neuroscience·2026

Antegrade versus retrograde ureteroscopy for large proximal ureteric stones: a meta-analysis.

BJU international·2026

Risk factors for antipsychotic- and antidepressant-associated liver function abnormalities: A retrospective unmatched case-control study.

Medicine·2026

Association between opioid use and treatment discontinuation in patients receiving nivolumab: a real-world database study.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026

Signal detection and characterisation of a novel drug-drug interaction between methadone and a synthetic cannabinoid receptor agonist.

British journal of pharmacology·2026

Related Experiment Videos

Management of paracetamol poisoning

Related Concept Videos

An ultra scale-down analysis of the recovery by dead-end centrifugation of human cells for therapy.

Use of adenovirus as a model system to illustrate a simple method using standard equipment and inexpensive excipients to remove live virus dependence on the cold-chain.

CB₁-independent mechanisms of Δ⁹-THCV, AM251 and SR141716 (rimonabant).

The micromass test: Is it subject to strain variation?

The endocannabinoid system and rimonabant: a new drug with a novel mechanism of action involving cannabinoid CB1 receptor antagonism--or inverse agonism--as potential obesity treatment and other therapeutic use.

A nonsynonymous substitution of cystatin A, a cysteine protease inhibitor of house dust mite protease, leads to decreased mRNA stability and shows a significant association with atopic dermatitis.

Efficacy and safety of upadacitinib in adults and adolescents for treatment of non-segmental vitiligo (Viti-Up): results of two phase 3 randomised controlled studies.

Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial.

Switch to once-weekly, single-tablet islatravir-lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial.

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Defining nonfatal opioid overdoses using administrative health data in the United States and Canada: A scoping review.

Opioid antagonist treatment in alcohol use disorder: extinction, reward memory, and the possible importance of timing.

Antegrade versus retrograde ureteroscopy for large proximal ureteric stones: a meta-analysis.

Risk factors for antipsychotic- and antidepressant-associated liver function abnormalities: A retrospective unmatched case-control study.

Association between opioid use and treatment discontinuation in patients receiving nivolumab: a real-world database study.

Signal detection and characterisation of a novel drug-drug interaction between methadone and a synthetic cannabinoid receptor agonist.

Related Experiment Videos

Management of paracetamol poisoning

Related Concept Videos

Related Articles